Overview for Alzheimer’s

‘Moving research into practice: Advanced dementia and end of life’ workshop

Alzheimer’s Society is running a workshop on the topic of ‘Moving research into practice: Advanced dementia and end of life care. This will take place on Wednesday 23 January in London (venue tbc). The Society would like to allocate up to two places to contacts working in the care home sector. If you are interested and available to participate in this event, please contact Malayka Rahman-Amin, Research Translation Manager at malayka.rahman@alzheimers.org.uk.

Written by Lakshini Mendis on Monday January 14, 2019
Tags: alzheimers, carehomeresearch, dementia, workshop

Join the Contact, Help, Advice and Information Network (CHAIN) Dementia Sub-group

Contact, Help, Advice and Information Network (CHAIN)  is an online mutual support network for people working in health and social care. It gives people a simple and informal way of contacting each other to exchange ideas and share knowledge.

The aim of the CHAIN dementia sub-group, of which Alzheimer's Society is the stake-holder, is to enable those with an interest in dementia care and research to connect and share knowledge and expertise.

Written by Lakshini Mendis on Wednesday September 5, 2018
Category: Dementia - Tags: dementia, carehome, alzheimers

Request for information: Models that support care providers being actively involved in research

In order to improve care for people living with dementia, Alzheimer’s Society is committed to funding care research, as well as supporting the translation of research into practice to help close the gap between the production and utilisation of knowledge.

Alzheimer's Society is currently scoping ideas for the launch of a funding call later this year, to explore different models for enabling enhanced care provider roles in research, in order to facilitate successful implementation.

Written by Lakshini Mendis on Monday July 30, 2018
Category: Setting up a study - Tags: alzheimers, carehomeresearch, dementia, funding

High prevalence of adverse effects with active buprenorphine use in care home residents living with dementia

Buprenorphine transdermal system is increasingly prescribed for people with advanced dementia. However, little is known about the potential adverse effects, such as nausea, sedation, or confusion, in people living with moderate to severe dementia and depressive symptoms in care homes.

This gap was addressed by the DEP.PAIN.DEM trial, which was funded by the Research Council of Norway and conducted by the Centre for Elderly and Nursing Home Medicine, University of Bergen.

Written by Lakshini Mendis on Tuesday May 29, 2018
Category: In the news - Tags: carehomeresearch, alzheimers, pain, medication